Sort   by:  
 Page size 
Genomicsena-DATASET-ErasmusMC-30-07-2021-14:00:05:691-768 - samples
Intellance-2: TruSight Tumor 170 panel based DNA-seq
EGAD00001007945 | EGA
Genomicsena-DATASET-ErasmusMC-30-07-2021-13:54:47:012-763 - samples
Intellance-2: rRNA-minus RNA-seq
EGAD00001007943 | EGA
Genomicsena-DATASET-ErasmusMC-30-07-2021-13:58:26:615-766 - samples
Intellance-2: TruSight Tumor 170 panel based RNA-seq
EGAD00001007944 | EGA
GenomicsIntellance-2: omics data on recurrent glioblastoma patients participating in the Intellance-2 clinical trial, prior to treatment.
This study contains omics data from patients from the Intellance-2 clinical trial, in which effectiveness of ABT414 in EGFR amplified recurrent glioblastoma patients was tested. Patients were randomly assigned to one of three arms: (1) standard of care treatement (TMZ or CCNU), (2) Only ABT414 and (...
EGAS00001005437 | EGA
Genomicsena-DATASET-ErasmusMC-29-07-2020-09:33:21:184-2056 - samples
RNA-Seq samples from the BELOB clinical trial study to find transcriptome associations with response to Bevacizumab and CCNU in glioblastoma patients
EGAD00001006329 | EGA
GenomicsBELOB: Ribo-minus RNA-seq data corresponding to 96x GBM samples from the BELOB trial.
Ribo-minus RNA-seq data corresponding to 96x GBM samples from the BELOB trial.
EGAS00001004570 | EGA
GenomicsBoard considering access to BELOB RNA-seq data
Data Access Committee EGAC00001001686
EGAC00001001686 | EGA
UnknownHeterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight.
Not available
S-EPMC7943191 | biostudies-literature
Sort   by:  
 Page size